Opioid prescribing for acute postoperative pain after cutaneous surgery

Little information is available to predict which patients require opioid analgesia following cutaneous surgery. When opioids are indicated, information regarding the optimal opioid agent selection and dosage is lacking. To make recommendations for opioid prescription after cutaneous surgery. A PubMe...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2019-03, Vol.80 (3), p.743-748
Main Authors: Lopez, Jonathan J., Warner, Nafisseh S., Arpey, Christopher J., Baum, Christian L., Brewer, Jerry D., Otley, Clark C., Gazelka, Halena M., Roenigk, Randall K.
Format: Article
Language:English
Subjects:
addiction
cutaneous surgery
dermatologic surgery
flap
Mohs micrographic surgery
narcotic
opioid
pain
public health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Little information is available to predict which patients require opioid analgesia following cutaneous surgery. When opioids are indicated, information regarding the optimal opioid agent selection and dosage is lacking. To make recommendations for opioid prescription after cutaneous surgery. A PubMed literature search was conducted to review the available literature. Recommendations are presented on the basis of available evidence and the opinion of the authors. Most patients undergoing cutaneous surgery do not require opioid analgesia. For those who do, the duration of pain warranting opioid analgesia is generally less than 36 hours. Opioid refill requests warrant a follow-up visit to ascertain the cause of ongoing pain after excisional procedures. The recommendations are not based on prospective randomized trials. The presented recommendations for opioid prescription practice are derived from available evidence, recommendations, and expert opinion.
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2018.09.032